Table 1.
Patient’s demographic and clinical characteristics.
| Influenza (N = 724) | SARS-CoV-2 (N = 642) | p-value | |
|---|---|---|---|
| Gender—male (%) | 340 (47) | 380 (59.2) | 0.15 |
| Age (median, IQR) | 67.00 (43–78) | 68.00 (53–78) | 0.023 |
| Death (%) | 51 (7.0) | 169 (26.3) | < 0.001 |
| Intubated (%) | 32 (4.4) | 123 (19.2) | < 0.001 |
| IORD (%) | 71 (9.8) | 215 (33.5) | < 0.001 |
| Body mass index (median, IQR) | 26.3 (22.7- 30) | 27.34 (24–30.9) | < 0.001 |
| Systolic blood pressuremin (median, IQR) | 110 (97–127) | 105 (95–120) | < 0.001 |
| Saturationmin (median, IQR) | 94 (90–97) | 90 (84–94) | < 0.001 |
| Albuminmin (median, IQR) | 3.5 (3.1–4) | 3 (2.5–3.5) | < 0.001 |
| Lymphocytesmin (median, IQR) | 0.60 (0.4–0.9) | 0.60 (0.4–0.9) | 0.191 |
| International normalized ratio (INR)max (median, IQR) | 1.11 (0.98–1.29) | 1.20 (1.10–1.39) | < 0.001 |
| C-reactive protein (CRP)max (median, IQR) | 7.05 (3.3–15.4) | 13.41 (6.22–24.94) | < 0.001 |
| White blood cellsmax (median, IQR) | 9.14 (6.6–12.4) | 10.32 (6.75–15.94) | < 0.001 |
| Ferritinmax (median, IQR) | 190.2 (61.2–351.4) | 743.35 (330.7–1600.5) | < 0.001 |
| Lactate dehydrogenasemax (median, IQR) | 537.5 (438- 684.7) | 737 (545–1093) | < 0.001 |
| Number of coinfections (%) | 0.006 | ||
| 0 | 661 (91.3) | 561 (87.4) | |
| 1 | 51 (7) | 52 (8.1) | |
| More than > 1 | 12 (1.7) | 29 (4.5) | |
| Hospitalization length (median, IQR) | 4 (2- 7) | 7 (3–14.75) | < 0.001 |
Data are shown as median (interquartile range (IQR)) or n (%) as indicated.
min, minimal levels; max, maximal levels, IORD, intubation or death.